|
Originally published In Press as doi:10.1074/jbc.M111552200 on December 27, 2001
J. Biol. Chem., Vol. 277, Issue 12, 10162-10172, March 22, 2002
Differential Regulation of Renal Na,K-ATPase by Splice Variants
of the Subunit*
Elena
Arystarkhova,
Claudia
Donnet,
Natalya K.
Asinovski, and
Kathleen J.
Sweadner
From the Laboratory of Membrane Biology, Neuroscience Center,
Massachusetts General Hospital, Charlestown, Massachusetts 02129
Received for publication, December 4, 2001
 |
ABSTRACT |
Sodium and potassium-exchanging adenosine
triphosphatase (Na,K-ATPase) in the kidney is associated with the subunit ( , FXYD2), a single-span membrane protein that modulates
ATPase properties. Rat and human occur in two splice variants, a
and b, with different N termini. Here we investigated their
structural heterogeneity and functional effects on Na,K-ATPase
properties. Both forms were post-translationally modified during
in vitro translation with microsomes, indicating that there
are four possible forms of . Site-directed mutagenesis revealed
Thr2 and Ser5 as potential sites for
post-translational modification. Similar modification can occur in
cells, with consequences for Na,K-ATPase properties. We showed
previously that stable transfection of a into NRK-52E cells resulted
in reduction of apparent affinities for Na+ and
K+. Individual clones differed in post-translational modification, however, and the effect on
Na+ affinity was absent in clones with full modification.
Here, transfection of b also resulted in clones with or without
post-translational modification. Both groups showed a reduction
in Na+ affinity, but modification was required for the
effect on K+ affinity. There were minor increases in ATP
affinity. The physiological importance of the reduction in
Na+ affinity was shown by the slower growth of a, b,
and b' transfectants in culture. The differential influence of the
four structural variants of on affinities of the Na,K-ATPase for
Na+ and K+, together with our previous finding
of different distributions of a and b along the rat nephron,
suggests a highly specific mode of regulation of sodium pump properties
in kidney.
 |
INTRODUCTION |
The Na,K-ATPase,1 or
sodium pump, is the principal enzyme in animal cells that maintains
ionic gradients of Na+ and K+ at the expense of
ATP hydrolysis. In kidney, the Na+ gradient provides the
driving force not only for the reabsorption of sodium, but also for
secondary transepithelial transport of various essential solutes and
water. Controlling sodium pump activity is thus an essential element of
renal regulation.
The Na,K-ATPase has two obligatory subunits, the catalytic subunit
and a glycoprotein, , which are encoded by multigene families (1).
Expression of and isoforms is developmentally regulated, and
appears to be species- and tissue-specific (2, 3). In several
experimental expression systems, the exchange of either or subunit isoforms affected enzymatic properties of the complex, most
notably affinities for K+ and Na+ (3).
Functional differences in intrinsic properties of Na,K-ATPase have been
reported in the kidney; the affinity for Na+ varies
significantly along the rat and rabbit nephron (4-7). This led to an
effort in many laboratories to determine whether and isoforms
could account for the differences, but no segment-specific localization
of isoforms other than 1 and 1 was found for either mRNA or
protein (8-12).
Two regulatory proteins that modulate intrinsic properties of the
Na,K-ATPase have now been identified in kidney: the Na,K-ATPase subunit (13, 14), and CHIF ("channel-inducing factor") (15, 16).
Based on sequence homology, both proteins belong to the FXYD gene
family, which unites small (5-15 kDa) single-span membrane proteins
including phospholemman (17), MAT-8 ("mammary tumor antigen-8")
(18), RIC ("related to ion channel") (19), as well as two new gene
products, called FXYD6 and FXYD7 (20). Although Na,K-ATPase is widely
distributed in kidney, expression of and CHIF is segment-specific.
co-localizes with Na,K-ATPase in proximal tubules, distal
convoluted tubules, and medullary thick ascending limb (21-23),
whereas CHIF co-localizes with the pump in collecting duct (16).
The functional significance of (FXYD2) for the Na,K-ATPase complex
was a mystery for a long time. The key properties of the Na,K-ATPase
(ouabain binding, enzymatic activity, and cation transport) can be
obtained without it (24-26). It is also not required for 
assembly and transport of functional units to the plasma membrane (27).
However, incorporation of a photoaffinity-labeled derivative of ouabain
into as well as suggested that it may comprise part of the
ouabain-binding site (13).
The first clear effect of on Na,K-ATPase transport properties was
detected by electrophysiological measurements in Xenopus oocytes. It influenced the apparent affinity of the Na,K-ATPase pump
current for extracellular K+ (28). An antibody against inhibited Na,K-ATPase in vitro and decreased affinity for
ATP (29). The functional role of was further assessed with
-transfected mammalian cells. In HEK cells, increased affinity
for ATP (30). NRK-52E cells express the same 1 1 combination as
kidney but no , and apparent affinities for Na+ and
K+ were higher than for 1 1 from renal medulla
(31). Stable transfection of a (the only known splice variant at the
time) resulted in a reduction of affinities for Na+ and
K+. This was observed with partially purified enzyme,
indicating a stable functional alteration of enzyme properties.
Interestingly, the modulation of Na+ affinity was abolished
by a post-translational modification of that occurred in cell
culture and that shifted its gel mobility (31). A comparable decrease
in apparent Na+ affinity has recently been ascribed to an
increase in K+ antagonism of cytoplasmic Na+
activation in -transfected HeLa cells (21). Similarly, was shown
to influence Na,K-ATPase pump current by lowering the apparent affinity
for intracellular Na+ (32). The injection of CHIF cRNA into
Xenopus oocytes, in contrast, resulted in an increase in
apparent affinity for Na+ (32). Taken together with the
almost complementary distributions of and CHIF along the rat
nephron (16, 22), the functional data correlate very well with the
differences in Na+ affinities in successive segments of the
nephron (4, 6, 7, 33).
In rat kidney, occurs as at least two splice variants, a and
b, with different N termini (20, 34, 35). The splice forms
colocalized in the inner stripe of the outer medulla in the thick
ascending limb of the loop of Henle (21, 23), and co-immunoprecipitation with each other and showed that they are
associated in macromolecular complexes (23). Our observations indicate
that their distribution in renal cortex and outer stripe of the outer
medulla, however, is strongly biased to different segments. a
predominated in proximal tubules, whereas b was detected only in
distal and connecting tubules and the thick ascending limb in the outer
stripe (23). Very recently, a third splice variant of has been
described in mouse (36), although not in human (37). All of the splice
variants in these characterized genes have different promoters, which
provides a basis for differential regulation of gene expression.
Here we have investigated the functional properties of subunit
splice variants. Others have reported that a and b have similar
effects on intrinsic properties of the pump. Both splice variants
decreased apparent affinity for Na+ without significant
alteration of K+ affinity in HeLa transfected cells (21)
and in Xenopus oocytes (32), and increased
Km for ATP in HeLa transfectants (21). We find,
however, that post-translational modifications that occur in some but
not all NRK-52E clones stably expressing a or b affect the final
enzyme properties; consequently, a can have modulating effects on
Na,K-ATPase activity different from that of b. Taken together with
the differential distribution of a and b in kidney, the
regulatory effects of on intrinsic properties of the Na,K-ATPase
appear to be subject to multiple layers of control. Preliminary reports
have been presented (38, 39).
 |
EXPERIMENTAL PROCEDURES |
Preparation of Na,K-ATPase from Kidney--
Isolation of
membranes and purification of Na,K-ATPase from rat kidney outer medulla
and whole mouse kidneys was performed by the Jørgensen procedure (40).
Briefly, microsomal fractions were collected by differential
centrifugation, followed by SDS treatment and equilibrium
centrifugation on sucrose density gradients.
Plasmid Construction and Site-directed Mutagenesis--
cDNA
for the b splice variant was obtained by reverse transcriptase-PCR
from total rat kidney RNA (CLONTECH). The primers were based on nucleotide sequences for rat b in the dbEST data base
(GenBankTM) plus EcoRI and BamHI restriction
sites for unidirectional cloning: forward degenerate primer,
5'-GCGAATTCCACCATGGAYAGGTGGTACYTG-3', where Y = (C/T);
reverse primer, 5'-CGCGGATCCCAGCTCATCTTCATTGAC-3'. Gel-purified
DNA was ligated into pIRES vector (CLONTECH)
containing an internal ribosome binding site and the neomycin
resistance gene. Several clones containing the full-length cDNA of
b were verified by nucleotide sequencing (GenBankTM AF233060).
Point mutations were introduced into the a cDNA in the pIRES
vector by PCR and confirmed by DNA sequencing.
In Vitro Protein Synthesis--
The full-length cDNAs of rat
a (wild type and mutated) and b were ligated into pT7 vector
(Novagen) and translated in vitro using the TNT-T7 system
(Promega) with or without addition of canine pancreatic microsomes
according to the manufacturer's procedure. The reaction was for 90 min
at 30 °C, followed by centrifugation in an Airfuge (Beckman) (10 min, 4 °C). The samples were washed with 100 mM NaCl and
25 mM HEPES, pH 7.4, and the final pellets were resuspended
in 315 mM sucrose, 1 mM EDTA, and 20 mM Tris-Cl, pH 7.5. Portions were dissolved in SDS sample
buffer, run on an SDS-Tricine gel (41), and transferred to
nitrocellulose. Detection of the newly synthesized proteins was with
the RCT-G1 antibodies against the C terminus of (31). Luciferase-T7
DNA was used as a positive nonradioactive control; samples without DNA
added served as negative controls for transcription/translation
background. Blots were scanned with a laser densitometer.
Transfectant Enzyme Preparation and Gel
Electrophoresis--
NRK-52E is a rat renal cell line ("normal rat
kidney") with polarized epithelial morphology. Transfection of
NRK-52E cells and selection of b-containing stable clones were
performed as before for a (31), and isolated clones were propagated
in the presence of G418 antibiotic selection. Purification of the
Na,K-ATPase from mock- or -transfected cells was as described (31).
Briefly, cells were grown in 75-cm2 flasks until confluent
in Dulbecco's modified Eagle's medium with 10% fetal bovine serum,
washed with Dulbecco's PBS, and frozen. Crude membranes from the
scraped cells were obtained by homogenization and differential
centrifugation. Final purification of Na,K-ATPase was with SDS
extraction, which leaves the protein in the lipid bilayer but removes
many contaminating proteins.
Electrophoresis was in SDS-Tricine gels (41). Proteins were transferred
to nitrocellulose, and the blots were incubated with specific
antibodies. Detection was with chemiluminescence (Pierce). The RCT-G1
polyclonal antibody raised against the C-terminal peptide of (31)
was employed to detect both splice variants of the protein. The RNGB
antibody (rat N terminus of b) (23) was used for b detection.
Monoclonal antibody McK1 was used to stain 1 (42).
Enzymatic Assays--
Na,K-ATPase activity was measured as a
function of Na+ concentration in media containing 3 mM Tris-ATP, 3 mM MgCl2, 30 mM histidine, pH 7.4, and in the presence of various
concentrations of K+ (5-100 mM). Na,K-ATPase
activity was also measured as a function of K+
concentration (0-20 mM) with fixed [Na+] at
140 mM. ATP activation curves were obtained with 140 mM Na+, 20 mM K+, and 4 mM Mg2+ in the reaction medium. All the
reactions were performed at 37 °C for 30-45 min with and without 3 mM ouabain, and ouabain-sensitive Pi release
was measured colorimetrically by using either Fiske-Subbarow or
Baginski methods, or by release of 32P from
[ -32P]ATP. Data were analyzed by nonlinear regression
using Sigma Plot Graph System (Jandel Scientific). Na+ and
K+ activation curves were fitted according to the Hill
model for ligand binding. Km values for ATP
stimulation were derived from the Michaelis-Menten equation, also by
nonlinear regression. Student's statistical test was used to assess differences.
An exception to the above methods applies to data replotted from Ref.
43. There, activity was assayed continuously in a spectrophotometric
coupled assay performed in a thermostatted cuvette. Assays were
performed with different starting K+ concentrations and
nominally zero Na+, and aliquots of NaCl were added
successively, allowing determination of a new slope with each addition.
 |
RESULTS |
Gel Mobility and Biosynthesis of the Structural
Variants--
Although it is well accepted that there are two splice variants in the rat (20, 21, 23, 32, 34, 35), the nature and
role of structural modifications of these variants have been controversial. Here we begin by examining the electrophoretic mobilities of forms found in kidney, and then use in
vitro translation of a and b to detect post-translational
modification of both splice variants.
Fig. 1A demonstrates band
resolution in gels of typical preparations of Na,K-ATPase from rat and
mouse kidney. The blot was stained with the RCT-G1 antibody that
recognizes the C terminus of , a site that is highly conserved
between species and identical in the splice variants. was seen as a
clear doublet in both species, although the resolution was
significantly better for mouse.2 A similar slower
migration of a was observed in Na,K-ATPase preparations from sheep
kidney (not shown). Based on gel mobility, we estimated the differences
in apparent molecular masses for splice variants as 1.5 and 2.5 kDa for
rat and mouse, respectively, with a appearing larger. For the rat,
the calculated molecular masses based on amino acid sequence are almost
identical, however: 7245.7 for a and 7234.8 for b, assuming no
modification or oxidation. Determination of the molecular masses by
mass spectrometry revealed 7184.0 ± 1 for rat a (with
carbamidomethyl cysteine and without initiator methionine) and
7337.9 ± 1 for rat b (with carbamidomethyl cysteine and with
acetylated methionine) (35), indicating that the larger species
actually migrates faster. The sequence of mouse a is four amino
acids longer (Fig. 1B), and the calculated difference between molecular
masses of unmodified mouse a and b is about 300 (7515.9 for a
versus 7204.7 for b). For both species, the calculated
masses are close enough that the proteins could co-migrate on SDS gels,
but splice variants of are generally seen as a doublet (23, 32,
35). Thus, the apparent difference in electrophoretic mobility must be
influenced by something else, such as net charge or a labile
post-translational modification.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 1.
Species-specific difference in
electrophoretic mobility of on SDS gels.
A, purified preparations of Na,K-ATPase from rat kidney
outer medulla and whole mouse kidneys were run on a 12.5% Tricine gel
and transferred to nitrocellulose, and the blot was stained with the
RCT-G1 antibody. Migration of a in mouse was significantly slower
than in rat. B, alignment of the N-terminal amino acid
sequences of a and b from rat and mouse.
|
|
We investigated the electrophoretic mobilities by analyzing proteins
translated in vitro from synthetic mRNA. First we
examined proteins made in reticulocyte lysates without addition of any microsomes. Newly synthesized proteins were analyzed on SDS-Tricine gels and stained with the RCT-G1 antibody, the blot was scanned with a
laser densitometer, and the scans were superimposed. As shown in Fig.
2A, the splice variants of rat
migrated at different rates, a slower than b, as shown with
tissue-derived samples (23, 35).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 2.
In vitro synthesis of the rat
subunit. cDNAs for rat a and b were
transcribed and translated in a reticulocyte system in the absence
(A) or presence (B and C) of canine
pancreatic microsomes (PM). Newly synthesized proteins were
run on Tricine-SDS gels. The blots were stained with the RCT-G1
antibody and scanned with a laser densitometer from top to bottom.
Staining of is expressed in arbitrary units, and its relative
position on the gel is marked with arrows.
|
|
Addition of endoplasmic reticulum to the reaction mixture permits
ribosome attachment and cotranslational membrane protein insertion.
When canine pancreatic microsomes were added to the reaction mixture,
the electrophoretic mobility of both proteins was decreased, implying
that both splice variants can be post-translationally modified (Fig. 2,
B and C). The shift observed for a was more pronounced than that for b, indicating either different types of
modification, or modification of more sites in a. Either way, the
difference in the shift between the splice variants is conjectural evidence that the location of the modification is in the spliced N-terminal segment, and that it occurs in the lumen of rough
microsomes. Beguin et al. (32) reported similar shifts in
electrophoretic mobility for both splice variants of synthesized in
a reticulocyte system supplemented with microsomes. Thus may exist
(at least in vitro) in four different structural forms:
a, a', b, and b', where the mark represents
post-translational modification(s).
To identify possible sites of modification by acylation or
esterification, we mutated the oxygen-containing residues of the N-terminal segment of . Thr2 and Ser5
residues are conserved in a from all mammalian species characterized so far (20). Site-directed mutagenesis to alanine was followed by
in vitro translation and electrophoresis. As shown in Fig. 3, both residues appeared to be important
for post-translational modification. Mutations of either
Thr2 or Ser5 almost completely blocked the
shift in mobility of a seen with pancreatic microsomes. However,
when Ser11, a potential site for modification in the
sequence shared by a and b, was replaced by Ala, migration of the
mutated protein was reduced to an intermediate position (Fig.
3C). In the absence of microsomes, all mutants migrated at
the same position as their unmutated form (data not shown). The data
are consistent with a possible cooperative modification of a at two
sites within the extracellular N-terminal splice domain of a, and
one in shared sequence. Alternatively, structural perturbation of the
extreme N terminus of a could prevent recognition by the modifying
enzyme(s).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of mutations on
electrophoretic mobility of a. cDNAs
for rat wild type or mutated a were transcribed and
translated in vitro, and analyzed as in Fig. 2.
Electrophoretic positions are shown for wild type a synthesized in
the presence (red) or absence (black) of
pancreatic microsomes and mutated a synthesized in the presence of
pancreatic microsomes (blue), run on the same gel.
Replacement of either Thr2 or Ser5 with Ala
(T2A and S5A, respectively) significantly blocked the shift in mobility
of a. Replacement of Ser11 (S11A) resulted in an
intermediate shift of mobility.
|
|
Expression of Two b Forms in NRK-52E Cells--
To test whether
b affects function of the pump, stable transfectants of NRK-52E
cells were generated as done previously for a (31). Expression of
b is shown in Fig. 4. The level of
expression in different clones, relative to subunit, varied between
20 and 80% of the level of b detected in rat kidney membranes
(mean, 50-60%). Two groups of clones were identified based on
electrophoretic mobility. In some clones (3 of 9 analyzed) b
comigrated with b synthesized in vitro (data not shown).
In the majority of clones, however, b migrated slower (compare
lane 1 with lanes 3 and 4, Fig. 4A). The shift in electrophoretic mobility was similar
to that observed in vitro upon the addition of canine
pancreatic microsomes (Fig. 2). The difference in migration of b in
transfectants was apparent in either crude membrane preparations or
partially purified enzyme (data not shown), indicating that difference
in mobility was not a purification artifact. Both N and C termini of
b were preserved in these preparations because the difference in
electrophoretic mobility was seen either with RCT-G1 (Fig. 4A) or RNGB (Fig. 4B) antibodies. This ruled out
the possibility of proteolysis, pointing to other post-translational
modification as the cause of differences in electrophoretic mobility
for b in transfected cells. Because the NRK-52E cell line is
morphologically heterogeneous (unpublished observations), cells with
different phenotypes might have different cell machinery with respect
to b modification similar to the differences already observed in a transfected cells (31).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 4.
Expression of b in
NRK-52E cells. A, purified preparations of Na,K-ATPase
from rat kidney (lane 2), b (lane
1), and b' (lanes 3 and
4) expressing clones were run on Tricine SDS gels (5.5 inches long). The blots were cut in the middle, and the upper portion
was stained with McK1 ( 1-specific antibody), whereas the bottom
panel was stained with RCT-G1 (antibody to the C terminus of ).
B, preparations of Na,K-ATPase from rat kidney
(lane 1), b (lane 2) and
b' (lane 3) expressing clones were
electrophoretically separated as in A, and stained with RNGB
(antibody to the N terminus of b). The shift in mobility was
detected with both -specific antibodies, suggesting a
post-translational modification of b. C, purified
preparations of Na,K-ATPase from a (partially modified)
(lane 1) and b' (lane 2)
clones were run separately or together (lane 3).
The blot was stained with RCT-G1 antibody. Unmodified a on the gel
could not be resolved from b.
|
|
The shift in mobility of b in different clones was reliably seen
only when electrophoretic separation was performed on long (5.5-inch)
Tricine gels (12.5% acrylamide), suggesting that the size of the
modifying group was rather small or that it cancelled some other subtle
effect on anomalous mobility. Conversely, when a was
post-translationally modified in NRK-transfected cells, the shift in
electrophoretic mobility was visible even on minigels (2.5-inch) (31).
Thus different types of modification (or numbers of residues modified)
were apparently exploited in a and b transfectants. The data are
in line with our in vitro translation studies, thus providing further support for the structural complexity of .
Fig. 4C shows an experiment in which membrane preparations
from clones containing modified b and heterogeneously modified a
(31) were mixed together and separated on a long (5.5-inch) Tricine
gel. Surprisingly, a doublet (not a triplet as expected) was observed
with the RCT-G1 antibodies, which shared a thick band at the lower
position. This implies that the electrophoretic mobility of modified
b can coincide with that of unmodified a on Tricine gels,
complicating the analysis of structural forms.
Functional Effects of the Splice Variants on Na,K-ATPase
Activity--
Na+, K+, and ATP ligand
dependences of the Na,K-ATPase from b-transfected cells were
determined and compared with those from a- and mock-transfected
cells. As in our previous study (31), we worked with individually
isolated stable clones, and all of the assays were performed on
partially purified preparations of Na,K-ATPase. Three clones expressing
b and six clones expressing b' were analyzed. The data shown
summarize multiple experiments.
Variations in the total specific activity between clones precluded any
evaluation of an effect of expression on
Vmax. Specific activity was in the range of
50-150 µmol of Pi/mg protein/h. As shown in Fig.
5A, the apparent affinity for
Na+ was significantly decreased when either b or b'
was expressed. Based on nonlinear regression analysis of data fit to
the Hill equation, K0.5 for Na+ was
shifted from 5.4 mM in wild-type NRK-52E cells to 7.3-7.4 mM for b when measured in the presence of 20 mM K+ (Table I).
Na,K-ATPase from rat kidney possessed an even lower apparent affinity
for sodium (9.5 ± 0.4 mM). Apparently,
post-translational modification of b did not influence its effect on
Na+ affinity because similar changes were observed in both
types of b-containing clones (Fig. 5A). The data
substantiate the conclusion that the major consequence of association with the Na,K-ATPase is a decrease of apparent affinity for
Na+ (21, 31, 32).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 5.
Effects of on
Na+, K+, and ATP affinity by Na,K-ATPase in
transfected NRK-52E cells. A, activity of partially
purified Na,K-ATPase from mock-transfected (red) or
b-transfected (blue and green) cells was
tested as a function of Na+ concentration at a fixed
K+ concentration of 20 mM. Data from
Na,K-ATPase purified from rat renal medulla (black) are
shown for comparison. Each set of data points is the mean ± S.D.
from at least four independent experiments (with duplicate
determinations) expressed as percentage of maximal Na,K-ATPase
activity. The data were fitted to Equation 1. Na+ affinity
of Na,K-ATPase was altered by b regardless of post-translational
modification: b (blue) and b' (green)
caused a similar decrease in apparent affinity for Na+.
B, preparations of Na,K-ATPase from rat kidney
(black), mock-transfected (red), or b and
b'-transfected cells (blue and green,
respectively) were assayed for ATPase activity as a function of
K+ concentration. Each set of data points shown is the
mean ± S.D. from at least five independent experiments (with
duplicate determinations) expressed as percentage of the ATPase
activity at 20 mM K+. The data were fitted to
Equation 1. Post-translational modification of b resulted in
modulation of the apparent affinity for K+. C,
purified preparations of Na,K-ATPase from rat kidney
(black), mock-transfected (red), a-transfected
(purple and cyan), and b-transfected
(blue and green) NRK-52E cells were assayed with
concentrations of ATP from 50 µM to 1.5 mM.
Data were analyzed by the Michaelis-Menten equation. Each set of data
is the mean ± S.D. from at least three independent experiments
(with duplicate determinations). Affinity for ATP was slightly
different in transfected cells expressing different structural forms of
.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Differential effects of structural forms of on affinity for
Na+ and K+
Affinities were determined with partially purified Na,K-ATPase
preparations from transfected NRK-52E cells or from rat kidney medulla.
Na+ and K+ activation curves were fitted according to a
cooperative model for ligand binding. The apparent affinity
K0.5 = K1/n, where
n is the Hill coefficient, nh. Clones
expressing a as a doublet were incompletely post-translationally
modified. The data shown for a doublet clones combine data published
previously (31) with additional experiments. The data
marked with double asterisks are taken from (31).
Multiple tests of significance were performed.
|
|
As we reported previously (31), the apparent affinity for
K+ was also higher in Na,K-ATPase from -deficient
NRK-52E cells than from rat kidney membranes, and so we evaluated the
contribution of b. The two groups of clones expressing b or b'
were examined, and data from multiple experiments were statistically
analyzed. Fig. 5B shows that expression of unmodified b
did not change the apparent affinity for K+ compared with
mock-transfected NRK cells. However, with b', K0.5 for K+ was significantly
increased from 0.45 ± 0.05 mM (control cells) to
0.75 ± 0.08 mM ( b' transfectants) (Table I). It
should be noted here that the assay was performed in the presence of
100 mM Na+, i.e. in conditions in
which the kinetics of activation by K+ depend on both the
intrinsic affinity for K+ and on competition between
extracellular Na+ and K+ ions. Beguin et
al. (32) have observed that this is affected by both and
CHIF in a voltage-dependent manner. Their data at 0 mV
(corresponding to our experiments in open membranes) show a similar
tendency to lower K+ affinity with , and an opposite
tendency to higher affinity when oocytes are hyperpolarized. In our
previous work (31), introduction of a caused a similar reduction in
the apparent affinity for K+ (from 0.44 ± 0.03 mM to 0.70 ± 0.04 mM, in mock- and
-transfected enzyme, respectively). However, the post-translational
modification of a did not alter the effect on K+
affinity, whereas it eliminated the reduction in apparent affinity for
Na+. Thus, the four structural forms of differentially
influenced the kinetic parameters of the Na,K-ATPase for its major
physiological ligands.
Similar to the two other kinetic parameters (apparent affinity for
Na+ and K+), the Km for ATP
(at the low affinity site) was lower in wild type NRK-52E cells
compared with rat kidney membranes (Table
II). Transfection with did not make
the ATP affinity more like that of the kidney enzyme, however. Instead
it further increased the affinity for at least two of the molecular
forms (Fig. 5C), b and fully modified a' (Table II).
However, we did not see any effects that reached statistical
significance on Km for ATP for either a
(partially modified) or b', nor did any of the changes reach
statistical significance compared with mock-transfected cells (Table
II). Although the difference in Km ATP displayed by
the two b forms was statistically significant from each other (p = 0.021 by Student's test), the effect was
nevertheless very modest. As mentioned above, the level of expression
in the transfected cells was never as high as in rat kidney membranes.
Thus, the possible interpretation is that association of unmodified
b or fully modified a with Na,K-ATPase may lead to a decrease in
Km values for ATP. This is roughly consistent with
prior reports (21, 30) and does not explain the higher
Km observed in   -containing rat kidney
membranes.
View this table:
[in this window]
[in a new window]
|
Table II
Effect of expression of on affinity for ATP in different cell lines
Km values for ATP for Na,K-ATPase isolated from
NRK-52E cells (transfected or mock-transfected) were calculated from
the Michaelis-Menten equation. Multiple tests of significance were
applied to our own data.
|
|
Mechanistic Analysis of the K+ Effect on
Na+ Affinity--
Two alternative equations describing
Hill (Equation 1) and noninteractive (Equation 2) models were used to
fit the Na+ affinity data (Fig.
6A).

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 6.
Kinetic analysis of
Na+/K+ competition.
A, in a typical experiment to determine apparent affinity
for Na+, Na,K-ATPase activity was measured in the presence
of different concentrations of Na+ and 100 mM
K+ in preparations from NRK-52E cells (open
circles) and a a transfectant (closed
circles). Lines represent the best fit to
Equation 1. The inset shows the best fit to Equation 1
(continuous line) as well as for Equation 2
(dashes). Curve-fitting was carried out using SigmaPlot
software (Jandel Scientific). The concentration variable was assumed to
be homoscedastic. The data are displayed as means ± S.E.
B, multiple individual experiments similar to the one
depicted in A were performed in the presence of fixed
concentrations of 5, 20, 50, or 100 mM K+.
K'Na were obtained by fitting with Equation 1
and were plotted against K+ concentration. The curves were
drawn by splines. C, to assess whether addition of choline
to keep ionic strength constant affects the linearity of the plot of
K'Na versus [K+], rat
renal medulla Na,K-ATPase was assayed with (closed
circles, A) and without choline
(open circles, B). The other data
(triangles, C) are also from an experiment with
rat renal medulla Na,K-ATPase, but data are replotted from Ref. 43, where the data were initially interpreted as fitting a
straight line. Dashed lines (A,
B, and C) are the best fit to Equation 3, and the
solid lines are drawn as splines. D,
K'Na versus [K+] for
the control NRK-52E cell preparation of panel 2 is shown for K'Na determined from either
Equation 1 (open circles) or Equation 2
(closed circles). K'Na for
Equation 2 is one eighth of maximal activity, whereas for Equation 1 it
is one half of maximal, but both plots are nonlinear.
|
|
|
(Eq. 1)
|
|
(Eq. 2)
|
Vm is the activity obtained
at optimum Na+ concentration, h is the Hill
coefficient, and K'Na is a measure of the apparent affinity for Na+. Equation 1 implies allosteric
interaction between the sites for Na+. Equation 2 would
apply if there is no interaction between three equivalent
Na+ binding sites, but all three sites must be loaded (44).
It should be noticed that K'Na, a measure of the
apparent affinity for Na+, has different meanings in each
equation, being the Na+ concentration that gives the
half-maximal velocity in Equation 1, but the concentration giving one
eighth of the maximal velocity in Equation 2. It can be seen in Fig.
6A that Equation 1 fit our data with less bias, suggesting
that the noninteracting site model may not apply.
The decrease in apparent affinity for Na+ observed in
-transfected HeLa cells has been analyzed kinetically and concluded to be caused by an increase in K+ antagonism of
Na+ binding at cytoplasmic sites (21). Here, an extensive
kinetic analysis was performed to evaluate the influence of
K+ concentration on apparent affinity for Na+
in a-transfected NRK-52E cells. Affinities obtained through fitting
the data with Equation 1 were plotted versus K+
concentration (Fig. 6B) for enzyme either lacking or
containing a. It can be seen that the apparent affinity for
Na+ decreased as K+ concentration rose, loosely
in agreement with prior work (21) and that, at all K+
concentrations, reduced the apparent Na+ affinity.
However, in our hands the shape for the plot of
K'Na versus K+
concentration was not linear, suggesting that mechanisms other than
K/Na antagonism alone are involved. As shown in Table
III, there were technical differences
such as in the concentration of free Mg2+, which will be
discussed below.
View this table:
[in this window]
[in a new window]
|
Table III
Experimental differences in K+/Na+
competition determinations
Concentrations are in mM. Free concentrations of
Mg2+ and ATP were calculated with the program WEBMAXC, version
2.10, taking into account the ionic strength and pH as well as the
listed Mg2+-binding ligands.
|
|
A nonlinear plot of K'Na versus
[K+] is unexpected, because in earlier studies with
various preparations (21, 43-46), K+ competition for
Na+ activation could be described by the simple equation
shown below.
|
(Eq. 3)
|
K'Na is the apparent affinity derived from
Equation 1 or 2, KNa is the Na+
affinity extrapolated to zero K+, and
KK is the affinity for K+ as a
competitor of Na+ binding. Fig. 6C shows,
however, that nonlinear plots can also be obtained with rat kidney
Na,K-ATPase preparations. We replotted old data from Ref. 43, which
were initially interpreted as linear, as well as new data obtained with
and without choline added to keep ionic strength constant. Addition of
choline shifted the curve to the right at the lower ionic strengths,
but did not eliminate the nonlinearity. The solid
lines are splines connecting the points, whereas the
dashed lines represent the fit to Equation 3,
which was poor. Although not as sigmoidal as the data obtained with the
NRK-52E transfectants, nonetheless a simple model based on competition
between Na+ and K+ for equivalent,
noninteracting sites was not supported in these experimental conditions.
Finally, to rule out any possibility that the method used to calculate
K'Na was responsible for the nonlinearity of the
final plot, we recalculated the Na+ affinity data for
mock-transfected NRK-52E cells using Equation 2 instead of Equation 1.
Fig. 6D illustrates the difference in absolute values for
K'Na (1/2 versus 1/8 of
Vmax) obtained with the two equations, and that
the data plotted either way were nonlinear.
Physiological Consequences of Expression--
We have reported
previously that a transfected cells displaying as a doublet had
slower growth rate than cells transfected with empty vector or cells
expressing a single band (47). Here we extended our studies with the
analysis of the b transfectants. As shown in Fig.
7A, cell growth was reduced
compared with the mock-transfected cells, and the delay was somewhat
greater than that caused in the partially modified a clones.
Practically no disparity in cell growth was observed between the clones
containing b or b' (Fig. 7B), suggesting that the
alteration in K+ affinity did not affect cell
proliferation. The 1.5-2-fold greater reduction in the b clones
than in the a clone in the second experiment may reflect a higher
level of expression in the b clones. Because all three groups of
clones ( a doublet, b, and b') possessed lower affinity for
Na+ than control cells, whereas clones with fully modified
a have normal growth rate (47), the interpretation
is that has a deleterious effect on cell proliferation because of a
reduction of Na,K-ATPase affinity for Na+.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 7.
Expression of affected NRK-52E growth rate. A and B
show two different sets of experiments in which the number of cells per
well was determined at 24-h intervals. Mock-transfected cells
(open circles), or NRK-5E cells transfected with
a (incompletely modified, solid circles), b
(solid squares), or b' (solid
triangles) were plated at 3 × 104
cells/well in six-well plates, harvested by trypsinization, and counted
with a hemacytometer. The data summarize the results of three
independent experiments where each data point represents triplicates.
The data were fitted to a logarithmic growth curve. Reduction in
Na+ but not in K+ affinity correlated with the
slower rate of cell proliferation.
|
|
 |
DISCUSSION |
Regulation of Na,K-ATPase activity in kidney is under several
layers of control (48). Although long term alterations involve changes
in the number of pump units at the level of gene expression, short term
regulators cause rapid modulation of enzyme activity either through
recruitment of a latent pool of Na,K-ATPase or through fine-tuning of
already existing complexes. The discovery that small single-span
membrane proteins (the subunit and CHIF) regulate the intrinsic
properties of the pump through association with  provides an
additional framework for understanding renal control of Na+
and K+ balance. A fundamental issue is why different splice
variants of are expressed in kidney and whether they serve distinct
functions. The major outcome is the observation that the splice
variants may in fact differentially influence the affinities for the
major ligands, Na+ and K+.
Structural Forms of --
The appearance of on SDS gels was
a mystery for a long time. The doublet was first interpreted as
post-translational modification of the protein based on in
vitro biosynthesis studies (14). In papers from 1999 and earlier,
interpretations of doublets as modified forms of a single subunit,
as well as interpretations of the significance of their susceptibility
to tryptic digestion, were confounded by not knowing about b
(29-31). More recently, genetic analysis (20, 36, 37), mass
spectroscopy (35), and immunostaining with specific antibodies (23, 35)
showed splice variants to form the doublet. We have confirmed these conclusions with in vitro translation; despite the very
close molecular masses of a and b, the proteins migrated
differently on SDS gels. The electrophoretic separation was even more
pronounced when canine microsomes were added. Evidence was obtained
that both splice variants can be post-translationally modified,
yielding four structural forms of . Our findings are in line with
the recent report that demonstrated that both splice variants of were susceptible to post-translational modification in
vitro, as was CHIF (32). Interestingly, our data showed that,
despite the extensive identity between a and b, their
susceptibility to modification in vitro appeared to be
different. The electrophoretic mobility of b was changed to a lesser
extent than that of a, implying involvement of the variable
N-terminal segment. This was supported by site-directed mutagenesis in
the N-terminal segment of a. When either Thr2 or
Ser5 was replaced by Ala, the change in mobility upon
addition of pancreatic microsomes was almost completely blocked. On the
other hand, some shift in mobility was retained when Ser11
was replaced. The results suggest that the observed changes in migration were not caused simply by substitution of hydrophobic for
oxygen-containing amino acids, and that modification of more than one
site may be involved in a, perhaps including Ser11 in
the shared sequence. Others have reported that mutations outside of the
N terminus (the common FXYD motif and C-terminal domain) had
no effect on formation of doublets (32).
The factors that determine the anomalous mobility of splice
variants are not clear, but something similar occurs with the catalytic
subunit of the Na,K-ATPase, where 3, the smallest among the four
known isoforms, migrates slowest. The N terminus of b has more bulky
hydrophobic residues (tryptophan, tyrosine) and less net negative
charge than that of a.
Mass spectroscopy of from rat kidney did not reveal any sign of
modified structure other than removal of the N-terminal methionine from
a and acetylation of the N-terminal methionine in b (35).
Although the size of the acetyl group is rather small to be detected on
SDS gels (42 Da), it could have changed the binding of SDS through an
effect on charge. Because we found functional differences between b
and b', the challenge would be to test whether deacetylation of b
could in fact lead to modulation of apparent affinity for
K+. Interestingly, there is a precedent from the literature
that acetylation of the N-terminal methionine in phospholamban, a
single-span regulatory protein from a different gene family,
significantly changed its inhibition of the sarcoplasmic,
endoplasmic reticulum Ca2+-ATPase (49).
The findings suggesting no other post-translational modification of in kidney (35) must be considered carefully. First, the
post-translational modification(s) could be chemically unstable in the
conditions used for peptide purification. Both bands had blocked N
termini, precluding direct sequencing (29), but this would not be
expected for a if it has no initiation methionine and no other added
mass. Second, the Na,K-ATPase used for mass spectroscopy was apparently
purified from rat kidney outer medulla (based on its high specific
activity). We, however, have identified proximal tubules as a potential
source for modified a, which migrated slower on SDS gels compared
with samples from outer medulla (23). Finally, post-translational
modification of the protein could be dependent on the physiological
status of the animal, and turned on and off in response to need. The
mass spectroscopy studies were performed with hypertensive rats (35).
Regulation of Na,K-ATPase is known to be implicated in hypertension
(50).
Three lines of evidence demonstrate that undergoes
post-translational modification when expressed in NRK-52E cells. First, shifts in electrophoretic mobility in transfected cells were always toward higher molecular weight species. Second, with specific antibodies, we showed that both N and C termini of b were preserved. (Unfortunately, the available antibodies against the N terminus of a
do not recognize the SDS-denatured protein with enough sensitivity to
do this experiment.) Third, the changes in the migration rate of a
and b from transfectants were similar to that observed during
in vitro translation with and without pancreatic microsomes.
Additional bands seen on Western blots of transfected HeLa
and HEK cells (21, 30, 35) have led to some confusion, however. In both
cell types, a in transfectants appeared to migrate faster than the
upper band of the kidney-derived doublet (35). Because the blot was
stained for the C terminus, this could be indicative of either
proteolysis at the N terminus of a in transfectants or a
post-translational modification of a in renal membranes. The lower
band seen in HEK- a could conceivably represent a product of
proteolysis or, alternatively, an adduct with a qualitatively different
effect on mobility. The position of the upper band in HeLa- b (21)
was much higher than would be expected for modified b based on
in vitro translation studies (this work or Ref. 32). Further
identification of cell-specific modifications of and elucidation of
its possible role in the Na,K-ATPase are required.
Functional Effects of : Apparent Affinities for Ions and
ATP--
General agreement has finally been reached that a major
effect of is related to Na+ affinity (21, 28, 30-32).
This is supported by our recent finding that renal Na,K-ATPase from knock-out mice displayed higher affinity for Na+ than that
from wild type animals.3
Beguin et al. (32) also showed in Xenopus oocytes
that decreased the apparent affinity for extracellular
K+, and only in the presence of extracellular
Na+, although it was not possible to evaluate the
functional impact of post-translational modification because oocytes
apparently lack the necessary machinery. The consequences of
post-translational modification and effects of on ATP affinity are
not well understood, and there are differences in technical details,
and in interpretations of results, that should be reconciled.
The observation that Na+ and K+ affinities
could be modified independently of each other through modification of
a and b (Table IV) implies that the
structural differences are functionally important. The only sequence
difference is in the short N-terminal stretch exposed outside the cell
(28, 30). It is attractive to hypothesize that this segment, through
its interaction with extracellular segments of and/or ,
influences the ion-binding sites within the ATPase complex. The
independent changes of Na+ and K+ affinity
(Table IV) do not follow either from the proposal that stabilizes
the E1 conformation, or from the proposal that K+ affinity
as a competitor of Na+ activation can somehow be varied
without effect on intrinsic Na+ affinity or distribution
between E1 and E2 forms (51). Furthermore, effects on
Km for ATP that appear to be consistent with stabilization of E1 are seen in all three transfected cell lines (Table
II), but do not explain the different ATP affinities among the cell
lines and -containing renal Na,K-ATPase. Experiments with knock-out animals also suggest that elimination of does not result
in a statistically significant change in ATP affinity in mouse
kidney.3
Divergent results and interpretations may be because of differences in
expression systems used. We analyzed multiple stable transfectants of
rat in normal rat kidney cells that express rat 1 1 and no
other known Na,K-ATPase subunit isoform. Pu et al. (21) have
ruled out that the use of human 1 instead of rat 1 influenced the
functional effect in transfections of HeLa cells with rat . However,
there is no evidence excluding functional association of with the
glycoprotein subunit. The human subunit(s) expressed in HEK
(human embryonic kidney) cells has not been determined to our
knowledge, but human embryonic kidney expresses 2 in vivo
(52). We have found both 1 and 3 to be expressed in HeLa cells
(data not shown). Although there is a high degree of homology between
human and rat 1, there are some structural variations (17/304
substitutions) that might affect subunit interactions, and 2 and
3 are significantly divergent (32-34% identity to 1).
K+/Na+ Antagonism--
Na+ is
normally rate-limiting for Na,K-ATPase enzyme activity, and so changes
in effective Na+ affinity should have direct physiological
consequences by regulating net activity in tissues. The practical issue
is that the concentration of intracellular K+ exceeds that
of Na+ by a factor of 30, and the ions are thought to be
transported in a ping-pong manner, utilizing the same sites. Of the
three cytoplasmic ion binding sites, the first two to be occupied do not have a marked preference for Na+, whereas the third
site apparently binds Na+ exclusively (53). The lack of
specificity of two of the sites results in
K+/Na+ competition.
Recently, Pu et al. (21) found linear relationships with
different slopes for apparent Na+ affinity plotted as a
function of concentration of competing K+, and concluded
that the mechanism of entailed an increase in K+/Na+ antagonism at the intracellular
Na+ binding sites, without effect on intrinsic
Na+ affinity (21, 51). They used a noninteractive site
model to calculate K'Na (Equation 2 shown
above), put forward originally by Garay and Garrahan in 1973 (44), and
showed data compatible with simple competition of K+ for
the Na+ sites (21). Sachs (45) reported similar linearity
in erythrocyte ghosts, like the original studies on erythrocyte ion
fluxes (44). The concept that changes
K+/Na+ competition has appeal because the
Blostein group has previously demonstrated tissue-specific (not
isoform-specific) differences in K+/Na+
antagonism (46, 54), which could conceivably be because of expression
of or other FXYD family members modulating the intrinsic properties
of the pump. Our data, in contrast, showed a nonlinear increase in
apparent affinity for Na+ with increasing concentrations of
K+ that tended to decline to a plateau. The presence of shifted the curve to higher values but the shift was not as strongly
dependent on K+ as described by Pu et al. (21).
In addition, the slopes did not have the same intercepts, suggesting
intrinsically different Na+ affinities in the presence and
absence of .
Although the final results and interpretation seem to be different from
ours, there are several practical considerations that may reconcile the
findings. The kinetic model used may have contributed to the
difference, although it cannot explain it alone. The model they used
assumes that K+ competes with Na+ binding to
any one of three equivalent sites on the cytoplasmic surface and
includes no provision for cooperativity or ordered binding and release.
More is known currently about the kinetics and properties of ion
binding than in 1973, and it is well documented that binding of the
first and second Na+ differs substantially from the binding
of the third Na+ in both character (electroneutral
versus electrogenic) and affinity (53, 55). Strictly ordered
release of the three Na+ ions has been also shown for
Na,K-ATPase (56). To analyze our current data with transfectants,
we derived K'Na from a cooperative model
(Equation 1) rather than a noncooperative one (Equation 2). It can be
seen that equation 1 showed less bias and better described our
experimental results, something that has also been found by others
(57). Measurement of pump currents as a function of Na+
concentration has also been shown to be well described by a Hill equation (32, 58, 59). For comparison, we re-analyzed our data with the
noninteractive model (Equation 2). The data were still nonlinear, but
the nonlinearity was less obvious. Therefore, it is plausible that
K+ competition for Na+ binding may be more
complex than the simplest model suggests, depending on the specific
conditions and occupancy of the sites.
A technical difference between the Pu et al. (21) data and
ours is that we did not keep the ionic strength constant, whereas they
kept constant ionic strength by addition of choline. Choline is not
inert in its effect on Na,K-ATPase, tending to favor the E1
conformation (60, 61). In control experiments performed with renal
medulla Na,K-ATPase preparations, we found a rightward shift from
choline addition and somewhat less nonlinearity, although the final
relation was still nonlinear.
The other relevant feature of competition at the cytoplasmic
Na+ sites is that it is by no means limited to
K+. Mg2+ is perhaps the best known
physiological competitor (62-65), but even Ca2+ and
organic cations are known to compete (65, 66). It is notable that the
free Mg2+ concentrations used by our group and Blostein's
group (as well as Ref. 45) were different by severalfold, as calculated
from association constants with ATP and EDTA, pH, and ionic strength (Table III). In preliminary experiments with 7 mM free
Mg2+, we observed a much lower overall Na+
affinity and a smaller effect of expression of in Na,K-ATPase from
NRK-52E transfectants (data not shown). This is consistent with the
concept that either Mg2+ or K+ can compete for
Na+ binding. Measurements of free Mg2+ in
cultured renal cells are in the range we used (67, 68), but free
Mg2+ in skeletal, cardiac, and smooth muscle cells is as
high as 1 mM (69).
Finally, the concentration of ATP may be a factor in determining
K+/Na+ apparent antagonism through its effect
on conformation, and this could introduce complexity either through the
experimental use of different ATP concentrations, or through effects of
on ATP affinity. However, if increases ATP affinity, it would
be expected to reduce K+ affinity as a competitor and thus
enhance Na+ apparent affinity, but this is the opposite of
what is observed in transfectants. Conceptually, this is consistent
with other evidence that effects of on Na+ affinity and
on ATP affinity are distinct (21, 51).
Although prior papers have attempted to analyze 's
function effects in terms of a shift in Na,K-ATPase E1-E2 equilibrium, we think that this theoretical framework is not helpful. The data suggesting that favors E1 (or that anti- antibody favors E2) are
mostly based on observations in nonphysiological concentrations of
ligands (29, 30), and seem to contradict the evidence that enhances
K+ competition at intracellular Na+ sites (21).
K+/Na+ competition should be inseparable from
the loading of E2(K), E1(K), and E1(Na) intermediates and therefore
inseparable from a tendency to remain in E2 (46, 53). has been
proposed to increase K+ affinity as a competitor without
affecting intrinsic Na+ affinity (51), but the very concept
of an intrinsic Na+ affinity is complicated because, by the
nature of vectorial transport, Na+ is always drained away.
Although Na+ binding affinities for the three cytoplasmic
sites can be estimated in the absence of ATP, a physically meaningful
binding affinity cannot be obtained in its presence (at temperatures
permissive for enzyme turnover) because of the failure to obtain
equilibrium as a result of transport (53). Consequently, all reported
Na+ affinities derived from enzyme during turnover are
"apparent" affinities, regardless of how terms may be defined.
These arguments, combined with the current concept that the pump cycle
does not have any single "power stroke" that can be uniquely
targeted to regulate activity (53), suggest that , as an extra
subunit, may impact multiple steps of the Post-Albers scheme. The
ability of different forms of to affect Na+,
K+, and ATP affinities separately argues that a
reductionist attempt to understand mechanism as an effect on any one
step may be difficult to accomplish.
A final physiological variable that we have not addressed is membrane
potential (70). In proteoliposomes containing renal Na,K-ATPase, a
potential positive on the cytoplasmic side (equivalent to cell
depolarization) increased Na+ affinity without altering the
affinity for competing K+ or organic cations (71). Membrane
potential has been shown to affect the magnitude of the effects of both
(28) and CHIF (32) to external Na+ and K+
measured in Xenopus oocytes. In short, the functional
consequences of expression for Na,K-ATPase properties is
potentially complex, and merits further investigation in intact cells.
In conclusion, apparent Na+ affinity can be affected by
multiple factors: voltage; K+, Mg2+, and ATP
concentrations for any given preparation; and expression of and
CHIF for any given set of conditions. The data suggest that the effect
has on the affinity of K+ as a competitor of
Na+ binding is not quantitatively explained by a simple
competition model.
Physiological Relevance of Expression--
It is notable that
the level of expression in stably transfected clones is lower than
that found in the renal medulla (21, 31). This may be because of the
fact that expression can slow growth rates. We routinely observed
that empty vector clones appeared several days before -expressing
clones, suggesting that there may be selective pressure against clones
with even higher levels of expression.
This laboratory has recently shown that expression can be induced
in NRK-52E cells by exposure to hypertonic media for six or more h
(72). Others have reported a similar finding in inner medullary
collecting duct cells (73). How this relates to conditions in the
kidney is a matter of some importance, particularly because the
expression of and each splice variant varies markedly in different
nephron segments (22, 23), and the hypertonicity of the nephron varies
with depth and physiological status.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant HL27653 (to K. J. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: 149-6118, Massachusetts General Hospital, 149 13th St., Charlestown, MA 02129. Tel.: 617-726-8579; Fax: 617-726-7526; E-mail:
sweadner@helix.mgh.harvard.edu.
Published, JBC Papers in Press, December 27, 2001, DOI 10.1074/jbc.M111552200
2
A third, larger splice variant, c, has been
reported for mouse (36), but if it was present in adult mouse kidney,
it was at levels that were not detected here.
3
D. H. Jones, Y. Li, K. J. Barr, E. Arystarkhova, R. K. Wetzel, K. J. Sweadner, G.-H. Fong, and
G. M. Kidder, manuscript in preparation.
 |
ABBREVIATIONS |
The abbreviations used are:
Na, K-ATPase, sodium
and potassium-exchanging adenosine triphosphatase;
HEK, human embryonic
kidney;
Tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine;
FXYD, gene nomenclature based on a conserved motif, Phe-X-Tyr-Asp,
pronounced like "fix-it.".
 |
REFERENCES |
| 1.
|
Lingrel, J. B.,
Orlowski, J.,
Shull, M. M.,
and Price, E. M.
(1990)
Prog. Nucleic Acid Res. Mol. Biol.
38,
37-89[Medline]
[Order article via Infotrieve]
|
| 2.
|
Sweadner, K. J.
(1989)
Biochim. Biophys. Acta
988,
185-220[Medline]
[Order article via Infotrieve]
|
| 3.
|
Blanco, G.,
and Mercer, R. W.
(1998)
Am. J. Physiol.
275,
F633-F650[Medline]
[Order article via Infotrieve]
|
| 4.
|
Feraille, E.,
Carranza, M. L.,
Rousselot, M.,
and Favre, H.
(1994)
Am. J. Physiol.
267,
F55-F62[Medline]
[Order article via Infotrieve]
|
| 5.
|
Feraille, E.,
Carranza, M. L.,
Buffin-Meyer, B.,
Rousselot, M.,
Doucet, A.,
and Favre, H.
(1995)
Am. J. Physiol.
268,
C1277-C1283[Medline]
[Order article via Infotrieve]
|
| 6.
|
Buffin-Meyer, B.,
Marsy, S.,
Barlet-Bas, C.,
Cheval, L.,
Younes-Ibrahim, M.,
Rajerison, R.,
and Doucet, A.
(1996)
J. Physiol.
490,
623-632[Abstract/Free Full Text]
|
| 7.
|
Barlet Bas, C.,
Cheval, L.,
Khadouri, C.,
Marsy, S.,
and Doucet, A.
(1990)
Am. J. Physiol.
259,
F246-F250[Medline]
[Order article via Infotrieve]
|
| 8.
| Farman, N., Corthesy-Theulaz, I., Bonvalet, J. P., and Rossier,
B. C. (1991) Am. J. Physiol. C468-C474
|
| 9.
|
Welling, P. A.,
Caplan, M.,
Sutters, M.,
and Giebisch, G.
(1993)
J. Biol. Chem.
268,
23469-23476[Abstract/Free Full Text]
|
| 10.
|
Tumlin, J. A.,
Hoban, C. A.,
Medford, R. M.,
and Sands, J. M.
(1994)
Am. J. Physiol.
266,
F240-F245[Medline]
[Order article via Infotrieve]
|
| 11.
|
Lucking, K.,
Nielsen, J. M.,
Pedersen, P. A.,
and Jorgensen, P. L.
(1996)
Am. J. Physiol.
271,
F253-F260[Medline]
[Order article via Infotrieve]
|
| 12.
|
Hayward, A. L.,
Hinojos, C. A.,
Nurowska, B.,
Hewetson, A.,
Sabatini, S.,
Oefner, P. J.,
and Doris, P. A.
(1999)
J. Hypertens.
17,
1081-1087[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Forbush, B., III,
Kaplan, J. H.,
and Hoffman, J. F.
(1978)
Biochemistry
17,
3667-3676[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Mercer, R. W.,
Biemesderfer, D.,
Bliss, D. P., Jr.,
Collins, J. H.,
and Forbush, B., III.
(1993)
J. Cell Biol.
121,
579-586[Abstract/Free Full Text]
|
| 15.
|
Attali, B.,
Latter, H.,
Rachamim, N.,
and Garty, H.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
6092-6096[Abstract/Free Full Text]
|
| 16.
|
Shi, H.,
Levy-Holzman, R.,
Cluzeaud, F.,
Farman, N.,
and Garty, H.
(2001)
Am. J. Physiol.
280,
F505-F512
|
| 17.
|
Palmer, C. J.,
Scott, D.,
and Jones, L. R.
(1991)
J. Biol. Chem.
266,
11126-11130[Abstract/Free Full Text]
|
| 18.
|
Morrison, B. W.,
Moorman, J. R.,
Kowdley, G. C.,
Kobayashi, Y. M.,
Jones, L. R.,
and Leder, P.
(1995)
J. Biol. Chem.
270,
2176-2182[Abstract/Free Full Text]
|
| 19.
|
Fu, X.,
and Kamps, M. P.
(1997)
Mol. Cell. Biol.
17,
1503-1512[Abstract]
|
| 20.
|
Sweadner, K. J.,
and Rael, E.
(2000)
Genomics
68,
41-56[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Pu, H. X.,
Cluzeaud, F.,
Goldshleger, R.,
Karlish, S. J. D.,
Farman, N.,
and Blostein, R.
(2001)
J. Biol. Chem.
276,
20370-20378[Abstract/Free Full Text]
|
| 22.
|
Wetzel, R. K.,
and Sweadner, K. J.
(2001)
Am. J. Physiol.
281,
F531-F545
|
| 23.
|
Arystarkhova, E.,
Wetzel, R. K.,
and Sweadner, K. J.
(2002)
Am. J. Physiol.
282,
F393-F407
|
| 24.
|
Freytag, J. W.
(1983)
FEBS Lett.
159,
280-284[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
DeTomaso, A. W.,
Xie, Z. J.,
Liu, G.,
and Mercer, R. W.
(1993)
J. Biol. Chem.
268,
1470-1478[Abstract/Free Full Text]
|
| 26.
|
Scheiner-Bobis, G.,
and Farley, R. A.
(1994)
Biochim. Biophys. Acta
1193,
226-234[Medline]
[Order article via Infotrieve]
|
| 27.
|
Geering, K.,
Beggah, A.,
Good, P.,
Girardet, S.,
Roy, S.,
Schaer, D.,
and Jaunin, P.
(1996)
J. Cell Biol.
133,
1193-1204[Abstract/Free Full Text]
|
| 28.
|
Beguin, P.,
Wang, X.,
Firsov, D.,
Puoti, A.,
Claeys, D.,
Horisberger, J. D.,
and Geering, K.
(1997)
EMBO J.
16,
4250-4260[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Therien, A. G.,
Goldshleger, R.,
Karlish, S. J. D.,
and Blostein, R.
(1997)
J. Biol. Chem.
272,
32628-32634[Abstract/Free Full Text]
|
| 30.
|
Therien, A. G.,
Karlish, S. J. D.,
and Blostein, R.
(1999)
J. Biol. Chem.
274,
12252-12256[Abstract/Free Full Text]
|
| 31.
|
Arystarkhova, E.,
Wetzel, R. K.,
Asinovski, N. K.,
and Sweadner, K. J.
(1999)
J. Biol. Chem.
274,
33183-33185[Abstract/Free Full Text]
|
| 32.
|
Beguin, P.,
Crambert, G.,
Guennoun, S.,
Garty, H.,
Horisberger, J.-D.,
and Geering, K.
(2001)
EMBO J.
20,
3993-4002[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Feraille, E.,
Rousselot, M.,
Rajerison, R.,
and Favre, H.
(1995)
J. Physiol.
488,
171-180[Abstract/Free Full Text]
|
| 34.
|
Sweadner, K. J.,
Rael, E.,
Wetzel, R. K.,
and Arystarkhova, E.
(2000)
in
Na/K-ATPase and Related ATPases
(Taniguchi, K.
, and Kaya, S., eds)
, pp. 543-546, Elsevier, Amsterdam
|
| 35.
|
Küster, B.,
Shainskaya, A., Pu, H. X.,
Goldshleger, R.,
Blostein, R.,
and Karlish, S. J. D.
(2000)
J. Biol. Chem.
275,
18441-18446[Abstract/Free Full Text]
|
| 36.
|
Jones, D. H.,
Golding, M. C.,
Barr, K. J.,
Fong, G.-H.,
and Kidder, G. M.
(2001)
Physiol. Genom.
6,
129-135[Abstract/Free Full Text]
|
| 37.
|
Sweadner, K. J.,
Wetzel, R. K.,
and Arystarkhova, E.
(2000)
Biochem. Biophys. Res. Commun.
279,
196-201[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Arystarkhova, E.,
Wetzel, R. K.,
Rael, E.,
Asinovski, N. K.,
and Sweadner, K.
(2000)
Biophys. J.
78,
279A
|
| 39.
|
Arystarkhova, E.,
Asinovski, N. K.,
and Sweadner, K. J.
(2000)
J. Am. Soc. Nephrol.
11,
24A
|
| 40.
|
Jorgensen, P. L.
(1974)
Methods Enzymol.
32,
277-290[Medline]
[Order article via Infotrieve]
|
| 41.
|
Schagger, H.,
and von Jagow, G.
(1987)
Anal. Biochem.
166,
368-379[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Arystarkhova, E.,
and Sweadner, K. J.
(1996)
J. Biol. Chem.
271,
23407-23417[Abstract/Free Full Text]
|
| 43.
|
Sweadner, K. J.
(1985)
J. Biol. Chem.
260,
11508-11513[Abstract/Free Full Text]
|
| 44.
|
Garay, R.,
and Garrahan, P. J.
(1973)
J. Physiol.
231,
297-325[Abstract/Free Full Text]
|
| 45.
|
Sachs, J. R.
(1986)
J. Physiol.
374,
221-244[Abstract/Free Full Text]
|
| 46.
|
Therien, A. G.,
Nestor, N. B.,
Ball, W. J.,
and Blostein, R.
(1996)
J. Biol. Chem.
271,
7104-7112[Abstract/Free Full Text]
|
| 47.
|
Arystarkhova, E.,
Wetzel, R. K.,
Asinovski, N. K.,
and Sweadner, K. J.
(2000)
in
Na/K-ATPase and Related ATPases
(Taniguchi, K.
, and Kaya, S., eds)
, pp. 489-496, Elsevier, Amsterdam
|
| 48.
|
Feraille, E.,
and Doucet, A.
(2001)
Physiol. Rev.
81,
345-418[Abstract/Free Full Text]
|
| 49.
|
Starling, A. P.,
Sharma, R. P.,
East, J. M.,
and Lee, A. G.
(1996)
Biochem. Biophys. Res. Commun.
226,
352-355[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Aperia, A.
(2001)
Curr. Hypertens. Rep.
3,
165-171[Medline]
[Order article via Infotrieve]
|
| 51.
|
Therien, A. G., Pu, H. X.,
Karlish, S. J. D.,
and Blostein, R.
(2001)
J. Bioenerg. Biomembr.
33,
407-414[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Burrow, C. R.,
Devuyst, O., Li, X.,
Gatti, L.,
and Wilson, P. D.
(1999)
Am. J. Physiol.
277,
F391-F403[Medline]
[Order article via Infotrieve]
|
| 53.
|
Apell, H.-J.,
and Karlish, S. J.
(2001)
J. Membr. Biol.
180,
1-9[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
Therien, A. G.,
and Blostein, R.
(1999)
Am. J. Physiol.
277,
C891-C898[Medline]
[Order article via Infotrieve]
|
| 55.
|
Domaszewicz, W.,
and Apell, H.-J.
(1999)
FEBS Lett.
458,
241-246[CrossRef][Medline]
[Order article via Infotrieve]
|
| 56.
|
Holmgren, M.,
Wagg, J.,
Benzanilla, F.,
Rakowski, R. F., De,
Weer, P.,
and Gadsby, D. C.
(2000)
Nature
403,
898-901[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Rossi, R. C.,
and Garrahan, P. J.
(1989)
Biochim. Biophys. Acta
981,
105-114
|
| 58.
|
Nakao, M.,
and Gadsby, D. C.
(1989)
J. Gen. Physiol.
94,
539-565[Abstract/Free Full Text]
|
| 59.
|
Barmashenko, G.,
Kockskamper, G.,
and Glitsch, H. G.
(1999)
J. Physiol.
517,
691-698[CrossRef][Medline]
[Order article via Infotrieve]
|
| 60.
|
Robinson, J. D.,
and Davis, R. L.
(1987)
Biochim. Biophys. Acta
912,
343-347[CrossRef][Medline]
[Order article via Infotrieve]
|
| 61.
|
Robinson, J. D.,
and Pratap, P. R.
(1991)
Biochim. Biophys. Acta
1069,
281-287[Medline]
[Order article via Infotrieve]
|
| 62.
|
Sachs, J. R.
(1988)
J. Physiol.
400,
575-591[Abstract/Free Full Text]
|
| 63.
|
Robinson, J. D.,
and Pratap, P. R.
(1991)
Biochim. Biophys. Acta
1061,
267-278[Medline]
[Order article via Infotrieve]
|
| 64.
|
Schneeberger, A.,
and Apell, H.-J.
(1999)
J. Membr. Biol.
168,
221-228[CrossRef][Medline]
[Order article via Infotrieve]
|
| 65.
|
Schneeberger, A.,
and Apell, H.-J.
(2001)
J. Membr. Biol.
179,
263-273[CrossRef][Medline]
[Order article via Infotrieve]
|
| 66.
|
Hoving, S.,
Bar-Shimon, M.,
Tijmes, J. J.,
Goldshleger, R.,
Tal, D. M.,
and Karlish, S. J. D.
(1995)
J. Biol. Chem.
270,
29788-29793[Abstract/Free Full Text]
|
| 67.
|
Dai, L.-J.,
Ritchie, G.,
Kerstan, D.,
Kang, H. S.,
Cole, D. E. C.,
and Quamme, G. A.
(2001)
Physiol. Rev.
81,
51-84[Abstract/Free Full Text]
|
| 68.
|
Touyz, R. M.,
Mercure, C.,
and Reudelhuber, T. L.
(2001)
J. Biol. Chem.
276,
13657-13663[Abstract/Free Full Text]
|
| 69.
|
Tashiro, M.,
and Konishi, M.
(1997)
Biophys. J.
73,
3358-3370[Medline]
[Order article via Infotrieve]
|
| 70.
|
Gadsby, D. C.,
Kimura, J.,
and Noma, A.
(1985)
Nature
315,
63-65[CrossRef][Medline]
[Order article via Infotrieve]
|
| 71.
|
Or, E.,
Goldshleger, R.,
and Karlish, S. J. D.
(1996)
J. Biol. Chem.
271,
2470-2477[Abstract/Free Full Text]
|
| 72.
|
Wetzel, R. K.,
Asinovski, N. K.,
Arystarkhova, E.,
and Sweadner, K. J.
(2001)
J. Am. Soc. Nephrol.
12,
43A
|
| 73.
|
Capasso, J. M.,
Rivard, C.,
and Berl, T.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
23,
3414-3419
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Lubarski, S. J. D. Karlish, and H. Garty
Structural and functional interactions between FXYD5 and the Na+-K+-ATPase
Am J Physiol Renal Physiol,
December 1, 2007;
293(6):
F1818 - F1826.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kobayashi, Y. Tahara, H. Takenaka, K. Mimura, and Y. Hayashi
Na+- and K+-Dependent Oligomeric Interconversion among {alpha}{beta}-Protomers, Diprotomers and Higher Oligomers in Solubilized Na+/K+-ATPase
J. Biochem.,
August 1, 2007;
142(2):
157 - 173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Arystarkhova, C. Donnet, A. Munoz-Matta, S. C. Specht, and K. J. Sweadner
Multiplicity of expression of FXYD proteins in mammalian cells: dynamic exchange of phospholemman and {gamma}-subunit in response to stress
Am J Physiol Cell Physiol,
March 1, 2007;
292(3):
C1179 - C1191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-N. T. Nguyen, D. P. Wallace, and G. Blanco
Ouabain Binds with High Affinity to the Na,K-ATPase in Human Polycystic Kidney Cells and Induces Extracellular Signal-Regulated Kinase Activation and Cell Proliferation
J. Am. Soc. Nephrol.,
January 1, 2007;
18(1):
46 - 57.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Han, J. Bossuyt, S. Despa, A. L. Tucker, and D. M. Bers
Phospholemman Phosphorylation Mediates the Protein Kinase C-Dependent Effects on Na+/K+ Pump Function in Cardiac Myocytes
Circ. Res.,
December 8, 2006;
99(12):
1376 - 1383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Pihakaski-Maunsbach, H. Vorum, B. Honore, S. Tokonabe, J. Frokiaer, H. Garty, S. J. D. Karlish, and A. B. Maunsbach
Locations, abundances, and possible functions of FXYD ion transport regulators in rat renal medulla
Am J Physiol Renal Physiol,
November 1, 2006;
291(5):
F1033 - F1044.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bossuyt, S. Despa, J. L. Martin, and D. M. Bers
Phospholemman Phosphorylation Alters Its Fluorescence Resonance Energy Transfer with the Na/K-ATPase Pump
J. Biol. Chem.,
October 27, 2006;
281(43):
32765 - 32773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Geering
FXYD proteins: new regulators of Na-K-ATPase
Am J Physiol Renal Physiol,
February 1, 2006;
290(2):
F241 - F250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bossuyt, X. Ai, J. R. Moorman, S. M. Pogwizd, and D. M. Bers
Expression and Phosphorylation of the Na-Pump Regulatory Subunit Phospholemman in Heart Failure
Circ. Res.,
September 16, 2005;
97(6):
558 - 565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. A. Mahmmoud, H. Vorum, and F. Cornelius
Interaction of FXYD10 (PLMS) with Na,K-ATPase from Shark Rectal Glands: CLOSE PROXIMITY OF Cys74 OF FXYD10 TO Cys254 IN THE A DOMAIN OF THE {alpha}-SUBUNIT REVEALED BY INTERMOLECULAR THIOL CROSS-LINKING
J. Biol. Chem.,
July 29, 2005;
280(30):
27776 - 27782.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. H. Jones, T. Y. Li, E. Arystarkhova, K. J. Barr, R. K. Wetzel, J. Peng, K. Markham, K. J. Sweadner, G.-H. Fong, and G. M. Kidder
Na,K-ATPase from Mice Lacking the {gamma} Subunit (FXYD2) Exhibits Altered Na+ Affinity and Decreased Thermal Stability
J. Biol. Chem.,
May 13, 2005;
280(19):
19003 - 19011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fuzesi, K.-E. Gottschalk, M. Lindzen, A. Shainskaya, B. Kuster, H. Garty, and S. J. D. Karlish
Covalent Cross-links between the {gamma} Subunit (FXYD2) and {alpha} and {beta} Subunits of Na,K-ATPase: MODELING THE {alpha}-{gamma} INTERACTION
J. Biol. Chem.,
May 6, 2005;
280(18):
18291 - 18301.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-G. Jia, C. Donnet, R. C. Bogaev, R. J. Blatt, C. E. McKinney, K. H. Day, S. S. Berr, L. R. Jones, J. R. Moorman, K. J. Sweadner, et al.
Hypertrophy, increased ejection fraction, and reduced Na-K-ATPase activity in phospholemman-deficient mice
Am J Physiol Heart Circ Physiol,
April 1, 2005;
288(4):
H1982 - H1988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Wetzel, J. L. Pascoa, and E. Arystarkhova
Stress-induced Expression of the {gamma} Subunit (FXYD2) Modulates Na,K-ATPase Activity and Cell Growth
J. Biol. Chem.,
October 1, 2004;
279(40):
41750 - 41757.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Lee, K. Hanspers, C. S. Barker, A. P. Korn, and J. M. McCune
Gene expression profiles during human CD4+ T cell differentiation
Int. Immunol.,
August 1, 2004;
16(8):
1109 - 1124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. A. Mahmmoud, G. Cramb, A. B Maunsbach, C. P. Cutler, L. Meischke, and F. Cornelius
Regulation of Na,K-ATPase by PLMS, the Phospholemman-like Protein from Shark: MOLECULAR CLONING, SEQUENCE, EXPRESSION, CELLULAR DISTRIBUTION, AND FUNCTIONAL EFFECTS OF PLMS
J. Biol. Chem.,
September 26, 2003;
278(39):
37427 - 37438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Wetzel and K. J. Sweadner
Phospholemman expression in extraglomerular mesangium and afferent arteriole of the juxtaglomerular apparatus
Am J Physiol Renal Physiol,
July 1, 2003;
285(1):
F121 - F129.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Cornelius and Y. A. Mahmmoud
Functional Modulation of the Sodium Pump: The Regulatory Proteins "Fixit"
Physiology,
June 1, 2003;
18(3):
119 - 124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Feschenko, C. Donnet, R. K. Wetzel, N. K. Asinovski, L. R. Jones, and K. J. Sweadner
Phospholemman, a Single-Span Membrane Protein, Is an Accessory Protein of Na,K-ATPase in Cerebellum and Choroid Plexus
J. Neurosci.,
March 15, 2003;
23(6):
2161 - 2169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Crambert and K. Geering
FXYD Proteins: New Tissue-Specific Regulators of the Ubiquitous Na,K-ATPase
Sci. Signal.,
January 21, 2003;
2003(166):
re1 - re1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Crambert, M. Fuzesi, H. Garty, S. Karlish, and K. Geering
Phospholemman (FXYD1) associates with Na,K-ATPase and regulates its transport properties
PNAS,
August 20, 2002;
99(17):
11476 - 11481.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|